NuCana PLC (NCNA)
US$ 1.50490.33%
Price Chart
Key Statistics
Market Cap
$ 14.92M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
88.82K
52W High
$ 10.79
52W Low
$ 0.03
Dividend Yield
0.00%
Beta
1.44
Technicals
50-Day MA
0.0664
200-Day MA
0.8132
52 Week High
10.79
52 Week Low
0.0325
About NCNA
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy ag.
Employees
20
Headquarters
Edinburgh, United Kingdom
CEO
Mr. Andrew Martin Kay B. Pharm
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg